Melospeech Inc. Accepts Nomination for HealthTech Startup of the YearRecognition highlights Melospeech's mission to deliver innovative, technology-enabled early intervention to underserved communities.
By: Melospeech Inc. This nomination recognizes Melospeech Inc.'s impact in advancing technology-enabled speech therapy, expanding access for underserved families, and building scalable tools that help practices operate with greater efficiency. Finalists across the Global Startup Awards network represent the top emerging companies, with 16 past finalists reportedly achieving unicorn status. "We're excited to stand alongside so many other health tech start-ups in officially accepting this nomination," Kelli Bavaro, Deputy CEO of Melospeech Inc., also shared her perspective on the company's nomination and use of proprietary technology. "As a speech-language pathologist, I've seen firsthand how powerful it is when we meet families where they are—both physically and culturally," The nomination also provides opportunities for Melospeech Inc. to gain additional visibility within the global innovation ecosystem, connect with influential industry leaders, and access potential investment opportunities through GSA Ventures. Melospeech Inc. will complete the next phase of the awards process and looks forward to the opportunity to represent the healthtech community on both national and international stages. About Melospeech Inc. Melospeech Inc. is a nationally recognized pediatric speech therapy provider specializing in early intervention, parent empowerment, and community-based care. Through innovative technology—including the MeloSuite, the SLPeaceBot™, and other proprietary tools—Melospeech has expanded its reach across underserved regions while streamlining clinical workflows and improving outcomes. Founded by Dr. Givona Sandiford, Melospeech has grown from a solo practice into a multi-state organization providing tens of thousands of sessions each year. End
|